Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-24-073771

Options or other derivatives

  • Chief Financial Officer acquired 267,470 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Little Paul Sean Chief Financial Officer 2024-06-13 Grant or award · Stock Option (right to buy) +267,470 267,470 D
Loading xslF345X05/ownership.xml…